Biocytogen Establishes Two Business Divisions To Distinguish Preclinical Models and Services (BioMice) from Antibody Drug R&D

BEIJING--(BUSINESS WIRE)--Aug 30, 2023--

Related Keywords

United States ,China ,Beijing ,Boston ,Massachusetts ,Shanghai ,San Francisco ,California ,Haimen Jiangsu ,Integrum Renmice ,Haimen Animal Center ,Animal Center ,Biocytogen Pharmaceuticals Beijing Co Ltd ,Mice Business Summary ,Business Wire ,Embryonic Stem Cell ,Homologous Recombination ,Extreme Genome Editing ,Beijing Animal Center ,Project Integrum ,Biomice Website ,Mice Inquiries ,Biocytogen Pharmaceuticals ,Business ,